202 related articles for article (PubMed ID: 24292099)
1. Combination therapy with iron chelation and vancomycin in treating murine staphylococcemia.
Luo G; Spellberg B; Gebremariam T; Lee H; Xiong YQ; French SW; Bayer A; Ibrahim AS
Eur J Clin Microbiol Infect Dis; 2014 May; 33(5):845-51. PubMed ID: 24292099
[TBL] [Abstract][Full Text] [Related]
2. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant
Dilworth TJ; Casapao AM; Ibrahim OM; Jacobs DM; Bowers DR; Beyda ND; Mercier RC
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617094
[TBL] [Abstract][Full Text] [Related]
4. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
Holubar M; Meng L; Alegria W; Deresinski S
Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050
[TBL] [Abstract][Full Text] [Related]
5. β-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone.
Dilworth TJ; Ibrahim O; Hall P; Sliwinski J; Walraven C; Mercier RC
Antimicrob Agents Chemother; 2014; 58(1):102-9. PubMed ID: 24145519
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
7. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia.
Schuch R; Lee HM; Schneider BC; Sauve KL; Law C; Khan BK; Rotolo JA; Horiuchi Y; Couto DE; Raz A; Fischetti VA; Huang DB; Nowinski RC; Wittekind M
J Infect Dis; 2014 May; 209(9):1469-78. PubMed ID: 24286983
[TBL] [Abstract][Full Text] [Related]
9. Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model.
Sande L; Sanchez M; Montes J; Wolf AJ; Morgan MA; Omri A; Liu GY
J Antimicrob Chemother; 2012 Sep; 67(9):2191-4. PubMed ID: 22661572
[TBL] [Abstract][Full Text] [Related]
10. Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus.
Sakoulas G; Okumura CY; Thienphrapa W; Olson J; Nonejuie P; Dam Q; Dhand A; Pogliano J; Yeaman MR; Hensler ME; Bayer AS; Nizet V
J Mol Med (Berl); 2014 Feb; 92(2):139-49. PubMed ID: 24297496
[TBL] [Abstract][Full Text] [Related]
11. A report on the first case of vancomycin-intermediate Staphylococcus aureus (VISA) in Hawai'i.
Chaiwongkarjohn S; Pramyothin P; Suwantarat N; Bankowski MJ; Koyamatsu T; Seifried SE; Bello EF
Hawaii Med J; 2011 Nov; 70(11):233-6. PubMed ID: 22162601
[TBL] [Abstract][Full Text] [Related]
12. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
[TBL] [Abstract][Full Text] [Related]
13. Impact of cefazolin co-administration with vancomycin to reduce development of vancomycin-intermediate Staphylococcus aureus.
Singh NB; Yim J; Jahanbakhsh S; Sakoulas G; Rybak MJ
Diagn Microbiol Infect Dis; 2018 Aug; 91(4):363-370. PubMed ID: 29807674
[TBL] [Abstract][Full Text] [Related]
14. The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia.
Honda H; Doern CD; Michael-Dunne W; Warren DK
BMC Infect Dis; 2011 Dec; 11():335. PubMed ID: 22142287
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
Truong J; Veillette JJ; Forland SC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133561
[TBL] [Abstract][Full Text] [Related]
16. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.
Roghmann MC
Arch Intern Med; 2000 Apr; 160(7):1001-4. PubMed ID: 10761966
[TBL] [Abstract][Full Text] [Related]
17. The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection.
McNeil JC; Kaplan SL; Vallejo JG
Pediatr Infect Dis J; 2017 Jun; 36(6):572-577. PubMed ID: 28027279
[TBL] [Abstract][Full Text] [Related]
18. Novel two-chain fatty acid-based lipids for development of vancomycin pH-responsive liposomes against
Makhathini SS; Kalhapure RS; Jadhav M; Waddad AY; Gannimani R; Omolo CA; Rambharose S; Mocktar C; Govender T
J Drug Target; 2019 Dec; 27(10):1094-1107. PubMed ID: 30901236
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia.
Seah J; Lye DC; Ng TM; Krishnan P; Choudhury S; Teng CB
Virulence; 2013 Nov; 4(8):734-9. PubMed ID: 24165210
[No Abstract] [Full Text] [Related]
20. Using MRSA Screening Tests To Predict Methicillin Resistance in Staphylococcus aureus Bacteremia.
Butler-Laporte G; Cheng MP; Cheng AP; McDonald EG; Lee TC
Antimicrob Agents Chemother; 2016 Dec; 60(12):7444-7448. PubMed ID: 27736763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]